Free Trial

Intellia Therapeutics (NTLA) Short Interest Ratio & Short Volume

$25.79
+1.16 (+4.71%)
(As of 07/12/2024 08:52 PM ET)

Intellia Therapeutics Short Interest Data

Current Short Interest
13,250,000 shares
Previous Short Interest
13,740,000 shares
Change Vs. Previous Month
-3.57%
Dollar Volume Sold Short
$296.54 million
Short Interest Ratio
8.4 Days to Cover
Last Record Date
June 30, 2024
Outstanding Shares
96,470,000 shares
Percentage of Shares Shorted
13.73%
Today's Trading Volume
1,984,800 shares
Average Trading Volume
1,575,461 shares
Today's Volume Vs. Average
126%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Intellia Therapeutics ?

Sign up to receive the latest short interest report for Intellia Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

NTLA Short Interest Over Time

NTLA Days to Cover Over Time

NTLA Percentage of Float Shorted Over Time

Intellia Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/30/202413,250,000 shares $296.54 million -3.6%N/A8.4 $22.38
6/15/202413,740,000 shares $345.56 million -6.5%N/A9.4 $25.15
5/31/202414,700,000 shares $314.29 million -3.1%N/A10.4 $21.38
5/15/202415,170,000 shares $397.76 million -1.8%N/A10.7 $26.22
4/30/202415,440,000 shares $330.42 million +5.8%N/A10.5 $21.40
4/15/202414,590,000 shares $334.40 million -1.6%N/A9.5 $22.92
3/31/202414,830,000 shares $407.97 million +9.9%N/A9.6 $27.51
3/15/202413,500,000 shares $382.05 million +7.0%N/A8.6 $28.30
2/29/202412,620,000 shares $405.35 million +8.5%N/A7.6 $32.12
2/15/202411,630,000 shares $331.11 million +6.0%N/A7.5 $28.47
1/31/202410,970,000 shares $261.31 million +5.0%N/A7.1 $23.82
1/15/202410,450,000 shares $289.15 million +2.9%N/A6.8 $27.67
12/31/202310,160,000 shares $309.78 million -3.2%N/A6.8 $30.49
12/15/202310,500,000 shares $323.19 million +6.6%N/A7.2 $30.78
11/30/20239,850,000 shares $291.86 million +4.0%N/A7.6 $29.63
11/15/20239,470,000 shares $251.71 million -1.7%N/A8 $26.58
10/31/20239,630,000 shares $241.23 million +18.6%N/A9.7 $25.05
10/15/20238,120,000 shares $242.22 million -1.1%N/A9.7 $29.83
9/30/20238,210,000 shares $259.60 million +6.2%N/A10.3 $31.62
9/15/20237,730,000 shares $276.89 million -1.4%N/A10 $35.82
8/31/20237,840,000 shares $293.84 million +7.5%N/A9.4 $37.48
8/15/20237,290,000 shares $282.92 million +13.9%N/A8.1 $38.81
7/31/20236,400,000 shares $270.91 million +3.1%N/A6.7 $42.33
7/15/20236,210,000 shares $272.99 million +2.5%N/A6.3 $43.96
6/30/20236,060,000 shares $247.13 million +5.4%N/A5.9 $40.78
6/15/20235,750,000 shares $262.03 million +9.7%N/A5.6 $45.57
5/31/20235,240,000 shares $195.24 million -11.8%N/A5 $37.26
5/15/20235,940,000 shares $271.81 million -13.0%N/A5.4 $45.76
4/30/20236,830,000 shares $257.83 million -2.0%N/A6.3 $37.75
4/15/20236,970,000 shares $265.98 million -6.1%N/A6.2 $38.16
3/31/20237,420,000 shares $276.54 million -5.8%N/A6.5 $37.27
3/15/20237,880,000 shares $322.13 million -2.7%N/A6.8 $40.88
2/28/20238,100,000 shares $325.38 million +6.6%N/A6.5 $40.17
2/15/20237,600,000 shares $317.53 million +3.4%N/A6.3 $41.78
1/31/20237,350,000 shares $311.93 million +12.0%N/A6.1 $42.44
1/15/20236,560,000 shares $246.92 million -1.1%N/A5.7 $37.64
12/30/20226,630,000 shares $231.32 million +11.4%N/A6 $34.89
12/15/20225,950,000 shares $217.35 million -1.2%N/A5.4 $36.53
11/30/20226,020,000 shares $309.79 million -9.5%N/A5.2 $51.46
11/15/20226,650,000 shares $351.92 million -5.1%N/A6.7 $52.92
Exposed: 3 CENT Crypto to Explode June 24th? (Ad)

Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... Today, he is now making the biggest crypto call of his ENTIRE career…

Click For My #1 FREE Crypto for 2024
10/31/20227,010,000 shares $369.99 million +6.5%N/A6.7 $52.78
10/15/20226,580,000 shares $344.59 million -4.2%N/A5.8 $52.37
9/30/20226,870,000 shares $384.45 million +2.8%N/A5.9 $55.96
9/15/20226,680,000 shares $458.11 million -2.8%N/A5.2 $68.58
8/31/20226,870,000 shares $412.61 million -1.4%N/A5.5 $60.06
8/15/20226,970,000 shares $476.89 million +3.4%10.2%5.4 $68.42
7/31/20226,740,000 shares $436.48 million -6.7%9.9%5 $64.76
7/15/20227,220,000 shares $456.88 million -3.5%10.6%5.6 $63.28
6/30/20227,480,000 shares $387.16 million +7.0%11.0%5.9 $51.76
6/15/20226,990,000 shares $286.10 million +5.4%10.3%5.9 $40.93
5/31/20226,630,000 shares $305.91 million -4.6%9.8%6.2 $46.14
5/15/20226,950,000 shares $337.77 million +11.4%10.2%5.8 $48.60
4/30/20226,240,000 shares $305.95 million +9.9%9.3%5.5 $49.03
4/15/20225,680,000 shares $340.40 million +1.1%8.5%5 $59.93
3/31/20225,620,000 shares $408.41 million +4.5%8.4%4.8 $72.67
3/15/20225,380,000 shares $313.49 million +1.5%8.0%4.8 $58.27
2/28/20225,300,000 shares $523.91 million +7.3%7.9%4.9 $98.85
2/15/20224,940,000 shares $486.69 million +2.9%7.4%5.2 $98.52
1/31/20224,800,000 shares $453.94 million +10.3%7.2%5.4 $94.57
1/15/20224,350,000 shares $397.46 million +1.9%6.5%5.4 $91.37
12/31/20214,270,000 shares $504.88 million -7.4%6.4%6 $118.24
12/15/20214,610,000 shares $563.80 million +16.1%6.9%6.2 $122.30
11/30/20213,970,000 shares $456.59 million +14.4%5.9%5.4 $115.01
11/15/20213,470,000 shares $463.38 million +4.8%5.2%4.6 $133.54
10/29/20213,310,000 shares $440.16 million -10.3%5.0%4.3 $132.98
10/15/20213,690,000 shares $481.51 million +5.7%5.6%4.1 $130.49
9/30/20213,490,000 shares $468.18 million -0.6%5.3%3.5 $134.15
9/15/20213,510,000 shares $528.04 million +2.3%5.3%1.7 $150.44
8/31/20213,430,000 shares $550.62 million -3.7%5.2%1.6 $160.53
8/13/20213,560,000 shares $553.19 million -2.2%5.4%1.6 $155.39
7/30/20213,640,000 shares $516.33 million +7.1%5.5%1.6 $141.85
7/15/20213,400,000 shares $469.54 million -26.6%5.2%1.5 $138.10
6/30/20214,630,000 shares $749.64 million -23.6%7.1%2.1 $161.91
6/15/20216,060,000 shares $537.22 million -7.3%10.1%4.7 $88.65
5/28/20216,540,000 shares $490.11 million -1.5%10.9%5.4 $74.94
5/14/20216,640,000 shares $404.24 million +0.5%N/A4.9 $60.88
4/30/20216,610,000 shares $529.33 million -9.3%N/A4.7 $80.08
4/15/20217,290,000 shares $556.59 million -14.4%N/A4.8 $76.35
3/31/20218,520,000 shares $615.48 million -2.5%N/A5.2 $72.24
3/15/20218,740,000 shares $572.64 million +8.0%N/A5 $65.52
2/26/20218,090,000 shares $464.93 million -5.6%N/A4.5 $57.47
2/12/20218,570,000 shares $590.64 million -9.3%N/A5.1 $68.92
1/29/20219,450,000 shares $604.52 million -2.3%N/A5.7 $63.97
1/15/20219,670,000 shares $805.51 million -4.7%N/A6.2 $83.30
12/31/202010,150,000 shares $574.29 million -8.1%N/A7.1 $56.58
12/15/202011,040,000 shares $575.18 million -5.6%N/A9 $52.10
11/30/202011,700,000 shares $460.75 million -7.1%N/A10.6 $39.38
11/15/202012,590,000 shares $418.37 million -2.3%N/A13 $33.23
10/30/202012,890,000 shares $321.61 million +0.8%N/A14.4 $24.95
10/15/202012,790,000 shares $316.04 million +7.1%N/A14.7 $24.71
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad)

AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.

Click here now for the full details of this stock that’s set to rocket in the AI revolution…
9/30/202011,940,000 shares $237.37 million +7.1%N/A14.8 $19.88
9/15/202011,150,000 shares $248.31 million +2.5%N/A13.9 $22.27
8/31/202010,880,000 shares $234.79 million -0.7%N/A13.8 $21.58
8/14/202010,960,000 shares $217.99 million +1.8%N/A11.8 $19.89
7/31/202010,770,000 shares $191.81 million +0.8%N/A10.7 $17.81
7/15/202010,680,000 shares $237.95 million -4.5%26.0%10.8 $22.28
6/30/202011,180,000 shares $228.30 million +11.5%28.0%11.4 $20.42
6/15/202010,030,000 shares $193.98 million -7.2%25.1%10.9 $19.34
5/29/202010,810,000 shares $189.28 million +2.0%24.4%11.5 $17.51
5/15/202010,600,000 shares $187.20 million +2.2%26.5%12.5 $17.66
4/30/202010,370,000 shares $139.68 million -3.5%26.1%13.6 $13.47
4/15/202010,750,000 shares $138.25 million +3.2%27.5%14.2 $12.86
3/31/202010,420,000 shares $151.92 million -2.2%26.6%13.8 $14.58
3/13/202010,656,600 shares $139.07 million +1.3%34.5%10.6 $13.05
2/28/202010,520,000 shares $126.13 million +1.4%34.1%15.5 $11.99
2/14/202010,380,000 shares $142.93 million +1.8%24.8%16.2 $13.77
1/31/202010,200,000 shares $125.46 million +6.8%27.2%15.8 $12.30
1/15/20209,550,000 shares $143.73 million -0.7%25.5%14.8 $15.05
12/31/20199,620,000 shares $132.76 million -3.6%25.7%15.9 $13.80
8/15/20198,571,100 shares $127.45 million -9.4%27.8%15.1 $14.87

NTLA Short Interest - Frequently Asked Questions

What is Intellia Therapeutics' current short interest?

Short interest is the volume of Intellia Therapeutics shares that have been sold short but have not yet been covered or closed out. As of June 30th, investors have sold 13,250,000 shares of NTLA short. Learn More on Intellia Therapeutics' current short interest.

What is a good short interest ratio for Intellia Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NTLA shares currently have a short interest ratio of 8.0. Learn More on Intellia Therapeutics's short interest ratio.

Which institutional investors are shorting Intellia Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Intellia Therapeutics: Walleye Trading LLC, PEAK6 Investments LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Intellia Therapeutics' short interest increasing or decreasing?

Intellia Therapeutics saw a decrease in short interest during the month of June. As of June 30th, there was short interest totaling 13,250,000 shares, a decrease of 3.6% from the previous total of 13,740,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Intellia Therapeutics' short interest compare to its competitors?

Here is how the short interest of companies in the sector of "medical" compare to Intellia Therapeutics: Editas Medicine, Inc. (20.36%), Cellectis S.A. (0.79%), Sangamo Therapeutics, Inc. (7.47%), CRISPR Therapeutics AG (18.43%), Lantheus Holdings, Inc. (6.31%), Neogen Co. (11.33%), Celldex Therapeutics, Inc. (10.61%), Myriad Genetics, Inc. (5.09%), QuidelOrtho Co. (4.91%), Achieve Life Sciences, Inc. (4.43%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.71 billion), TC Energy Co. ($2.95 billion), Moderna, Inc. ($2.63 billion), Royal Caribbean Cruises Ltd. ($2.53 billion), Paychex, Inc. ($2.03 billion), Cencora, Inc. ($2.03 billion), Tractor Supply ($1.91 billion), Rivian Automotive, Inc. ($1.78 billion), Chesapeake Energy Co. ($1.50 billion), and United Therapeutics Co. ($1.40 billion). View all of the most shorted stocks.

What does it mean to sell short Intellia Therapeutics stock?

Short selling NTLA is an investing strategy that aims to generate trading profit from Intellia Therapeutics as its price is falling. NTLA shares are trading up $1.16 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Intellia Therapeutics?

A short squeeze for Intellia Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NTLA, which in turn drives the price of the stock up even further.

How often is Intellia Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NTLA, twice per month. The most recent reporting period available is June, 30 2024.



This page (NASDAQ:NTLA) was last updated on 7/15/2024 by MarketBeat.com Staff

From Our Partners